Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Azelaic acid + glycolic acid is a topical combination therapy used primarily in dermatology for the treatment of facial hyperpigmentation (such as melasma) and mild-to-moderate acne. Azelaic acid is a dicarboxylic acid with anti-inflammatory, antibacterial, comedolytic, and tyrosinase-inhibiting properties, making it effective against acne and hyperpigmentation by reducing inflammation, inhibiting melanin production, and normalizing keratinization[7][8]. Glycolic acid is an alpha hydroxy acid (AHA) that acts as a chemical exfoliant by breaking down the bonds between dead skin cells on the surface of the skin, promoting cell turnover and improving texture[3][10]. When combined, glycolic acid enhances penetration of azelaic acid by exfoliating the stratum corneum. Clinical studies have shown that this combination is at least as effective as hydroquinone or tretinoin for treating hyperpigmentation in darker-skinned patients and mild-to-moderate acne while offering superior tolerability compared to tretinoin[1][6]. The combination may cause mild local irritation such as peeling or dryness but generally has a favorable safety profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on azelaic acid + glycolic acid.